Navigation Links
WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
Date:2/18/2010

SHANGHAI, Feb. 18 /PRNewswire-Asia-FirstCall/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter of 2009 after the New York Stock Exchange closes on Monday, March 8, 2010 (which will be Tuesday morning, March 9, 2010 Shanghai time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

The earnings release will be available on the investor relations section of its website at http://www.wuxiapptec.com .

Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 9:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, March 9, 2010, to discuss the fourth-quarter 2009 financial results and recent business activities. The conference call may be accessed by calling:

    
    
    United States:          1-866-519-4004
    China (Landline):       800-819-0121
    China (Mobile):         400-620-8038
    Hong Kong:              800-930-346
    United Kingdom:         0-808-234-6646
    International:          +65-6733-0019
    Conference ID:          57898803

A telephone replay will be available two hours after the call's completion at:

    
    
    United States:            1-866-214-5335
    China North:              10-800-714-0386
    China South:              10-800-140-0386
    Hong Kong:                800-901-596
    United Kingdom:           0-800-731-7846
    International:            +61-2-8235-5000
    Conference ID:            57898803

A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com .

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

    
    
    For more information, please contact:
    
    Ronald Aldridge
    Director of Investor Relations
    WuXi PharmaTech (Cayman) Inc.
    Tel:   +1-201-585-2048
    Email: Ron_Aldridge@wuxiapptec.com

Web: http://www.wuxiapptec.com  

SOURCE WuXi PharmaTech (Cayman) Inc.

RELATED LINKS
http://www.wuxiapptec.com

'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
2. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
3. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
4. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
5. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
6. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
7. Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call
8. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
9. VirtualScopics Schedules Third Quarter 2009 Earnings Announcement
10. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
11. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology:
(Date:7/20/2017)... PITTSBURGH, PA (PRWEB) , ... July 20, 2017 , ... ... is of utmost importance. The adjustable beds used in such facilities are specially designed ... not feature adequate arm support. , An inventor from Rochester, Ind., has invented ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced ... Proceeds will be used to complete regulatory submissions and fund final engineering and ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... that further expand its existing adherence automation lines. The ATP® Mini and ... advanced technology of TCG’s standard products, but at a size and price point ...
(Date:7/20/2017)... , ... July 20, 2017 , ... A budget proposal ... cost – of - living - adjustment (COLA) is a bad deal for older ... “chained” consumer price index (CPI) would grow even more slowly than the conventional one ...
(Date:7/20/2017)... , ... July 19, 2017 , ... At Creekwood Dental ... of temporomandibular joint (TMJ) treatment and dental implants in Waco, TX, using ... scanner and the T-Scan™ by Tekscan®, they can capture details in the oral cavity ...
Breaking Medicine News(10 mins):